Lucy Meunier

Montpellier, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Motivation and barriers to physicians' academic career in gastroenterology in France.

Motivation and barriers to physicians' academic career in gastroenterology in France.

Journal: Medical education online
Published: August 26, 2026

Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury?

Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury?

Journal: JHEP reports : innovation in hepatology
Published: July 16, 2026

Are King's College and Clichy-Villejuif criteria used for liver transplantation still appropriate? A retrospective study over a 25-year period.

Are King's College and Clichy-Villejuif criteria used for liver transplantation still appropriate? A retrospective study over a 25-year period.

Journal: Annals of intensive care
Published: April 03, 2026

Liver biopsy findings and clinical correlates in immune-mediated liver injury from checkpoint inhibitors.

Liver biopsy findings and clinical correlates in immune-mediated liver injury from checkpoint inhibitors.

Journal: Hepatology communications
Published: March 11, 2026

Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitis.

Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitis.

Journal: JHEP reports : innovation in hepatology
Published: August 09, 2025

Ursodeoxycholic Acid: Not Just a Marker, but a Therapeutic Opportunity in Cholestatic CHILI.

Ursodeoxycholic Acid: Not Just a Marker, but a Therapeutic Opportunity in Cholestatic CHILI.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 26, 2025

Features and Outcomes of 280 Patients With Idiosyncratic Drug-Induced Liver Injury: The REFHEPS Prospective Study.

Features and Outcomes of 280 Patients With Idiosyncratic Drug-Induced Liver Injury: The REFHEPS Prospective Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 04, 2025

Disparities in transplant access and outcomes after first cirrhosis decompensation in alcohol-related liver disease.

Disparities in transplant access and outcomes after first cirrhosis decompensation in alcohol-related liver disease.

Journal: JHEP reports : innovation in hepatology
Published: April 04, 2025

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.

Journal: The lancet. Gastroenterology & hepatology
Published: March 28, 2025

Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor-Induced Liver Injury.

Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor-Induced Liver Injury.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 30, 2024

VCTE and Liver Transplantation: Is There Still a Role for Liver Biopsy?

VCTE and Liver Transplantation: Is There Still a Role for Liver Biopsy?

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 28, 2024

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial.

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial.

Journal: Journal of hepatology
Published: November 29, 2024
Showing 1-12 of 77

Last Updated: 09/26/2026